Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, Texas Health Research & Education Institute requires that all faculty and planning committee members disclose financial relationships relevant to the content being planned and/or presented. The relevant financial relationships are those they may have with any commercial interest producing health care goods or services consumed by or used on patients. Disclosures are provided below for the CME activity chair, planners and content reviewer.

Chair Credentials
Chair
Leslie Secrest, MD
Psychiatrist
Texas Health Presbyterian Hospital Dallas*
Dallas, TX
*Doctors on the medical staff practice independently and are not employees or agents of the hospital.

Planning Committee
Scott Dahl, MBA, BS
Mary Digison, RN
Christina Martin
Marilyn Peterson, MA, CCMEP
Sandra Pinkerton, PhD, CCMEP
Gwen Pond
Elizabeth Weidmer-Mikhail, MD

Disclosure
Dr. Secrest, planners and staff have no relevant financial relationship with proprietary entities producing health care goods or services related to the content of this CME activity.

Content Reviewer
Madhukar Trivedi, MD
Betty Jo Hay Distinguished Chair in Mental Health,
Professor, Department of Psychiatry,
University of Texas Southwestern Medical Center
Dallas, TX

Madhukar H. Trivedi, M.D. has disclosed the following relevant financial relationships with proprietary entities producing health care goods or services related to the content of this CME activity:

Receives consulting fees from Abbott Laboratories, Inc., Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb Company, Cephalon, Inc., Eli Lilly & Company, Evotek, Forest Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson PRD, Lundbeck, MedAvante, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Pfizer, Inc., PgxHealth, Rexahn Pharmaceuticals, SHIRE Development, Takeda,
Tal Medical/Puretech Venture and Transcept.

Receives research support from Agency for Healthcare Research and Quality, National Institute of Mental Health, National Institute on Drug Abuse, Naurex, Targacept and Valient.